CR20160227A - Nuevo compuesto para el tratamiento de hipoglicemia severa - Google Patents

Nuevo compuesto para el tratamiento de hipoglicemia severa

Info

Publication number
CR20160227A
CR20160227A CR20160227A CR20160227A CR20160227A CR 20160227 A CR20160227 A CR 20160227A CR 20160227 A CR20160227 A CR 20160227A CR 20160227 A CR20160227 A CR 20160227A CR 20160227 A CR20160227 A CR 20160227A
Authority
CR
Costa Rica
Prior art keywords
treatment
new compound
severe hypoglycemia
hypoglycemia
severe
Prior art date
Application number
CR20160227A
Other languages
English (en)
Inventor
Jorge Alsina-Fernandez
Robert Chadwick Cummins
Lili Guo
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52273565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20160227(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CR20160227A publication Critical patent/CR20160227A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se refiere un nuevo compuesto útil en el tratamiento de hipoglicemia.
CR20160227A 2013-12-18 2016-05-18 Nuevo compuesto para el tratamiento de hipoglicemia severa CR20160227A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361917716P 2013-12-18 2013-12-18
PCT/US2014/069644 WO2015094876A1 (en) 2013-12-18 2014-12-11 Novel compound for treatment of severe hypoglycemia

Publications (1)

Publication Number Publication Date
CR20160227A true CR20160227A (es) 2016-07-12

Family

ID=52273565

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160227A CR20160227A (es) 2013-12-18 2016-05-18 Nuevo compuesto para el tratamiento de hipoglicemia severa

Country Status (22)

Country Link
US (1) US20160311882A1 (es)
EP (1) EP3083667A1 (es)
KR (1) KR20160075826A (es)
CN (1) CN105829340A (es)
AP (1) AP2016009267A0 (es)
AR (1) AR098615A1 (es)
AU (1) AU2014366425B2 (es)
BR (1) BR112016010635A2 (es)
CA (1) CA2930596A1 (es)
CR (1) CR20160227A (es)
DO (1) DOP2016000142A (es)
EA (1) EA201690966A1 (es)
HK (1) HK1224305A1 (es)
IL (1) IL245491A0 (es)
MA (1) MA39110B1 (es)
MX (1) MX2016007988A (es)
PE (1) PE20160847A1 (es)
PH (1) PH12016501183A1 (es)
SG (1) SG11201604237PA (es)
TN (1) TN2016000208A1 (es)
TW (1) TW201609128A (es)
WO (1) WO2015094876A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI622596B (zh) 2015-10-26 2018-05-01 美國禮來大藥廠 升糖素受體促效劑
WO2019140024A1 (en) 2018-01-12 2019-07-18 Eli Lilly And Company Combination therapy
CA3128922A1 (en) 2019-02-05 2020-08-13 Eli Lilly And Company Glucagon analog agonists and methods of using the same
MA55504A (fr) 2019-04-01 2022-02-09 Novo Nordisk As Anticorps dirigés contre le liraglutide et leur utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2477286C2 (ru) 2007-01-05 2013-03-10 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМ ЗНАЧЕНИЕМ pH
EP2249853A4 (en) * 2008-01-30 2012-12-26 Univ Indiana Res & Tech Corp ESTER BASED PEPTIDE PRODRUGS
US8450270B2 (en) * 2008-06-17 2013-05-28 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
US8703701B2 (en) * 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
UA126465C2 (uk) * 2011-06-10 2022-10-12 Ханмі Сайенс Ко., Лтд. Пептид, що має активність оксинтомодуліну, та фармацевтична композиція для лікування ожиріння, яка його містить
WO2013004983A1 (en) * 2011-07-04 2013-01-10 Imperial Innovations Limited Novel compounds and their effects on feeding behaviour

Also Published As

Publication number Publication date
CN105829340A (zh) 2016-08-03
EA201690966A1 (ru) 2016-12-30
PH12016501183A1 (en) 2016-07-25
MA39110B1 (fr) 2018-04-30
US20160311882A1 (en) 2016-10-27
IL245491A0 (en) 2016-06-30
EP3083667A1 (en) 2016-10-26
AR098615A1 (es) 2016-06-01
BR112016010635A2 (pt) 2017-12-05
CA2930596A1 (en) 2015-06-25
TW201609128A (zh) 2016-03-16
AP2016009267A0 (en) 2016-06-30
DOP2016000142A (es) 2016-07-15
HK1224305A1 (zh) 2017-08-18
AU2014366425B2 (en) 2016-12-08
TN2016000208A1 (en) 2017-10-06
KR20160075826A (ko) 2016-06-29
MA39110A1 (fr) 2017-09-29
WO2015094876A1 (en) 2015-06-25
MX2016007988A (es) 2016-09-09
PE20160847A1 (es) 2016-09-10
SG11201604237PA (en) 2016-07-28
AU2014366425A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
MX372669B (es) Un compuesto que modifica el empalme del gen de foxm1 para usarse en la profilaxis o tratamiento de cáncer.
MX377534B (es) Compuestos para usarse en el tratamiento de hiperinsulinemia.
IN2013DE00266A (es)
CU20160003A7 (es) Pirazololpiridinaminas sustituidas
UY34575A (es) Composiciones y métodos para el tratamiento de diabetes y/u obesidad
AR097668A1 (es) Colorante-polímero
CR20160227A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
ECSP16024798A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
ECSP16024805A (es) Nuevo compuesto para el tratamiento de hipoglicemia severa
DOP2016000067A (es) Nuevo inhibidor de sglt1
BR112015021575A2 (pt) composição fungicida
CL2016000171A1 (es) Formulación de metaxalona.
IN2013MU03768A (es)
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
UA106373C2 (ru) Применение поллентара как средства фригопротекторного действия
CL2012000641S1 (es) Lavamanos.
TR201314933A2 (tr) Bakteriyel enfeksiyonların tedavisine yönelik bir kompozisyon.
TN2011000399A1 (fr) دراجة كهربائية ذات شحن الي
TN2011000372A1 (fr) جهاز مراقبة وتحكم في استهلاك المياه
UA72478U (ru) Применение полентара как средства фригопротекторного действия